HRTX · Heron Therapeutics, Inc. · Debt
$0.30
+0.00 (+1.62%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$56.23M
Shares
189.85M
Volume · Oct 22
4.74M
Avg daily vol (3M)
2.5M
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Noncurrent convertible notes payable | 2026-06-30 | USD 33,925,000 | 10-Q filed 2026-08-10 |
| Operating lease liabilities | 2026-06-30 | USD 5,704,000 | 10-Q filed 2026-08-10 |
Related accounting measures — not additional borrowingCarrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.
| |||
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
818033
CUSIP
427746102
13F (30d)
25 filings
25 filers
Visit website
Investor relations